Recognizing the place of trials with treatment of physician's choice as the control arm.
University of Leeds and St James' Institute of Oncology, Leeds, United Kingdom C.J.Twelves@leeds.ac.uk.
Chris
C
Twelves
St James' Institute of Oncology, Leeds, United Kingdom.
Maria
M
Jove
Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Javier
J
Cortes
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases
D018719:Erb-b2 Receptor Tyrosine Kinases